Source |
Code |
Name |
Case count |
Share of cases (%) |
PURCH |
PURCH_ATC(L01XE33) |
Palbociclib |
312 |
|
PURCH |
PURCH_ATC(L01XE04) |
Sunitinib |
264 |
|
PURCH |
PURCH_ATC(L01XE01) |
Pivagabine |
263 |
|
PURCH |
PURCH_ATC(L01XE31) |
Nintedanib |
176 |
|
PURCH |
PURCH_ATC(L01XE11) |
Pazopanib |
129 |
|
PURCH |
PURCH_ATC(L01XE05) |
Sorafenib |
120 |
|
PURCH |
PURCH_ATC(L01XE26) |
Dihydrostreptomycin |
109 |
|
PURCH |
PURCH_ATC(L01XE23) |
Dabrafenib |
103 |
|
PURCH |
PURCH_ATC(L01XE03) |
Beclometasone |
95 |
|
PURCH |
PURCH_ATC(L01XE10) |
Everolimus |
89 |
|
PURCH |
PURCH_ATC(L01XE27) |
Ibrutinib |
86 |
|
PURCH |
PURCH_ATC(L01XE25) |
Trametinib |
77 |
|
PURCH |
PURCH_ATC(L01XE13) |
Afatinib |
72 |
|
PURCH |
PURCH_ATC(L01XE21) |
Regorafenib |
71 |
|
PURCH |
PURCH_ATC(L01XE18) |
Ruxolitinib |
64 |
|
PURCH |
PURCH_ATC(L01XE06) |
Dasatinib |
51 |
|
PURCH |
PURCH_ATC(L01XE17) |
Axitinib |
50 |
|
PURCH |
PURCH_ATC(L01XE07) |
Lapatinib |
48 |
|
PURCH |
PURCH_ATC(L01XE02) |
Gefitinib |
39 |
|
PURCH |
PURCH_ATC(L01XE08) |
Nilotinib |
39 |
|
PURCH |
PURCH_ATC(L01XE16) |
Crizotinib |
22 |
|
PURCH |
PURCH_ATC(L01XE36) |
Alectinib |
22 |
|
PURCH |
PURCH_ATC(L01XE35) |
Osimertinib |
20 |
|
PURCH |
PURCH_ATC(L01XE15) |
Vemurafenib |
19 |
|
PURCH |
PURCH_ATC(L01XE29) |
Rolapitant |
16 |
|
PURCH |
PURCH_ATC(L01XE41) |
Name not found |
15 |
|
PURCH |
PURCH_ATC(L01XE46) |
Name not found |
15 |
|
PURCH |
PURCH_ATC(L01XE14) |
Bosutinib |
11 |
|
PURCH |
PURCH_ATC(L01XE24) |
Ponatinib |
7 |
|